Prognostic value of hepatocyte nuclear factors 4α and 1α identified by tissue microarray in resectable hepatocellular carcinoma
暂无分享,去创建一个
E. Yu | H. Lee | Seungbong Han | J. Shim | Sung‐Gyu Lee | H. Kang | Young‐Joo Lee
[1] R. Santambrogio,et al. Hepatic Resection for “BCLC Stage A” Hepatocellular Carcinoma. The Prognostic Role of Alpha-Fetoprotein , 2012, Annals of Surgical Oncology.
[2] Lei Qiu,et al. Recombinant adenovirus carrying the hepatocyte nuclear factor‐1alpha gene inhibits hepatocellular carcinoma xenograft growth in mice , 2011, Hepatology.
[3] H. El‐Serag,et al. Level of α-fetoprotein predicts mortality among patients with hepatitis C-related hepatocellular carcinoma. , 2011, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.
[4] Shimul A. Shah,et al. Rising incidence and demographics of hepatocellular carcinoma in the USA: what does it mean? , 2011, Expert review of gastroenterology & hepatology.
[5] S. Fan,et al. Continuous Improvement of Survival Outcomes of Resection of Hepatocellular Carcinoma: A 20-Year Experience , 2011, Annals of surgery.
[6] J. Bruix,et al. Management of hepatocellular carcinoma: An update , 2011, Hepatology.
[7] Ewout W Steyerberg,et al. Extensions of net reclassification improvement calculations to measure usefulness of new biomarkers , 2011, Statistics in medicine.
[8] Kun Wu,et al. Hepatocyte nuclear factor 4 alpha suppresses the development of hepatocellular carcinoma. , 2010, Cancer research.
[9] M. Makuuchi,et al. Significance of Alpha-Fetoprotein and Des-γ-Carboxy Prothrombin in Patients with Hepatocellular Carcinoma Undergoing Hepatectomy , 2009, Annals of Surgical Oncology.
[10] Bei-fang Ning,et al. Hepatocyte nuclear factor 4α attenuates hepatic fibrosis in rats , 2009, Gut.
[11] Jun-Ping Zhang,et al. Differentiation therapy of hepatocellular carcinoma in mice with recombinant adenovirus carrying hepatocyte nuclear factor‐4α gene , 2008, Hepatology.
[12] E. Yu,et al. Metastatic tumor antigen 1 is closely associated with frequent postoperative recurrence and poor survival in patients with hepatocellular carcinoma , 2008, Hepatology.
[13] M. Pencina,et al. Evaluating the added predictive ability of a new marker: From area under the ROC curve to reclassification and beyond , 2008, Statistics in medicine.
[14] C. de Toma,et al. Association of CYP1B1 germ line mutations with hepatocyte nuclear factor 1alpha-mutated hepatocellular adenoma. , 2007, Cancer research.
[15] G. Tiberio,et al. Early and Late Recurrence After Liver Resection for Hepatocellular Carcinoma: Prognostic and Therapeutic Implications , 2006, Annals of surgery.
[16] Sung‐Gyu Lee,et al. How I do it: assessment of hepatic functional reserve for indication of hepatic resection. , 2005, Journal of hepato-biliary-pancreatic surgery.
[17] D. Ovchinnikov,et al. Progression of HCC in mice is associated with a downregulation in the expression of hepatocyte nuclear factors , 2004, Hepatology.
[18] M. Noguchi,et al. Expression of HNFs and C/EBPα is correlated with immunocytochemical differentiation of cell lines derived from human hepatocellular carcinomas, hepatoblastomas and immortalized hepatocytes , 2003, Cancer science.
[19] M. Kojiro,et al. Immunohistologic study on the expressions of α‐fetoprotein and protein induced by vitamin K absence or antagonist II in surgically resected small hepatocellular carcinoma , 2001, Hepatology.
[20] S. Fan,et al. Different risk factors and prognosis for early and late intrahepatic recurrence after resection of hepatocellular carcinoma , 2000, Cancer.
[21] S. Fan,et al. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma. , 2000, Annals of surgery.
[22] K. Covinsky,et al. Assessing the Generalizability of Prognostic Information , 1999, Annals of Internal Medicine.
[23] B. Haddad,et al. Rescue of the HNF4 --> HNF1alpha pathway in hepatoma variant cells containing human chromosome 12. , 1998, Genomics.
[24] Y. Hayashi,et al. Expression of HNF‐1α and HNF‐1β in various histological differentiations of hepatocellular carcinoma , 1998 .
[25] M. Weiss,et al. Hepatocyte Nuclear Factor 4 Provokes Expression of Epithelial Marker Genes, Acting As a Morphogen in Dedifferentiated Hepatoma Cells , 1998, The Journal of cell biology.
[26] M. Kasuga,et al. Expression ratio of hepatocyte nuclear factor-1 to variant hepatocyte nuclear factor-1 in differentiation of hepatocellular carcinoma and hepatoblastoma. , 1996, Journal of hepatology.
[27] K. Kaestner,et al. Expression of hepatocyte-enriched nuclear transcription factors in mouse liver tumours. , 1996, Carcinogenesis.
[28] M. Yaniv,et al. Hepatocyte Nuclear Factor 1 Inactivation Results in Hepatic Dysfunction, Phenylketonuria, and Renal Fanconi Syndrome , 1996, Cell.
[29] S. Cereghini. Liver‐enriched transcription factors and hepatocyte differentiation , 1996, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.
[30] B. Bois-Joyeux,et al. Members of the CAAT/enhancer-binding protein, hepatocyte nuclear factor-1 and nuclear factor-1 families can differentially modulate the activities of the rat alpha-fetoprotein promoter and enhancer. , 1994, The Biochemical journal.
[31] S. Thorgeirsson,et al. Expression of hepatic transcription factors during liver development and oval cell differentiation , 1994, The Journal of cell biology.
[32] I. Talianidis,et al. An indirect negative autoregulatory mechanism involved in hepatocyte nuclear factor-1 gene expression. , 1993, Nucleic acids research.
[33] H. El‐Serag,et al. Level of Alpha-Fetoprotein Predicts Mortality among Patients with Hepatitis C-Related Hepatocellular Carcinoma , 2011 .
[34] N. Lazarevich. Molecular mechanisms of alpha-fetoprotein gene expression. , 2000, Biochemistry. Biokhimiia.
[35] H. Nakabayashi,et al. Expression of HNF-1 alpha and HNF-1 beta in various histological differentiations of hepatocellular carcinoma. , 1998, The Journal of pathology.